Chemotherapy for Prostate Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|7|819-837

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.7, 2006-03, pp. : 819-837

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Strategies Against Prostate Cancer – Pt(II)-Based Chemotherapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4678-4687

Bentham Science Publishers

Access to resources Recommend Favorite

A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer

By Beardsley Emma  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1652-1659

Springer Publishing Company

Access to resources Recommend Favorite

Metronomic Chemotherapy for Metastatic Prostate Cancer: A `Young' Concept for Old Patients?

By Fontana Andrea  

Drugs & Aging, Vol. 27, Iss. 9, 2010-09 ,pp. : 689-696

Adis International

Access to resources Recommend Favorite

High-risk localised prostate cancer: multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy

By Eastham James A  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 291-295

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant chemotherapy in patients with clinically well advanced prostate cancer (stage T3) after surgery `cannot be recommended'

By  

Inpharma, Vol. 1, Iss. 1228, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite